Literature DB >> 7726341

An in vitro investigation into the effects of repetitive motion and nonsteroidal antiinflammatory medication on human tendon fibroblasts.

L C Almekinders1, A J Baynes, L W Bracey.   

Abstract

Soft tissue injuries due to repetitive motion are common sports injuries and are often treated with antiinflammatory therapies. We investigated the in vitro effects of repetitive motion and nonsteroidal antiinflammatory medication on human tendon fibroblasts. In addition, we studied the effects related to the presence of inflammatory cells. Repetitive motion was associated with an increased release of prostaglandin E2 and increased deoxyribonucleic acid (DNA) and protein synthesis. The presence of nonsteroidal antiinflammatory medication decreased prostaglandin E2 release and DNA synthesis but increased protein synthesis. Contact with macrophages caused a marked additional increase in prostaglandin E2 and a concomitant increase in DNA synthesis. Release of interleukin-6 by the macrophages also suggested that this cytokine plays a role in the response to repetitive motion. Our results can aid in the search for a more scientific approach to the treatment of soft tissue injuries associated with repetitive motion. They suggest that nonsteroidal antiinflammatory medication may have potentially negative effects during the proliferative phase of a healing since it was associated with decreased DNA synthesis. However, it may be beneficial in the maturation and remodeling phase since it stimulated protein synthesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7726341     DOI: 10.1177/036354659502300120

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  28 in total

Review 1.  Pathophysiological tissue changes associated with repetitive movement: a review of the evidence.

Authors:  Ann E Barr; Mary F Barbe
Journal:  Phys Ther       Date:  2002-02

2.  Tennis elbow.

Authors:  Shyam Kumar; David Stanley; Neil G Burke; Hannan Mullett
Journal:  Ann R Coll Surg Engl       Date:  2011-09       Impact factor: 1.891

Review 3.  Oral cyclo-oxygenase 2 inhibitors versus other oral analgesics for acute soft tissue injury: systematic review and meta-analysis.

Authors:  Peter Jones; Rain Lamdin
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

Review 4.  Non-steroidal anti-inflammatory drugs (NSAIDs) for treating acute ankle sprains in adults: benefits outweigh adverse events.

Authors:  Michel P J van den Bekerom; Arnout Sjer; Matthijs P Somford; Gythe H Bulstra; Peter A A Struijs; Gino M M J Kerkhoffs
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-01-29       Impact factor: 4.342

Review 5.  Tendon biomechanics and mechanobiology--a minireview of basic concepts and recent advancements.

Authors:  James H-C Wang; Qianping Guo; Bin Li
Journal:  J Hand Ther       Date:  2011-09-17       Impact factor: 1.950

Review 6.  An overview of structure, mechanical properties, and treatment for age-related tendinopathy.

Authors:  B Zhou; Y Zhou; K Tang
Journal:  J Nutr Health Aging       Date:  2014-04       Impact factor: 4.075

7.  Negative effects of parecoxib and indomethacin on tendon healing: an experimental study in rats.

Authors:  Sigbjorn Dimmen; Lars Engebretsen; Lars Nordsletten; Jan Erik Madsen
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-03-19       Impact factor: 4.342

8.  Tissue engineering approaches for the construction of a completely autologous tendon substitute.

Authors:  Bassetto Franco; Vindigni Vincenzo; Dalla Vedova Alessandro; Carolin Tonello; Giovanni Abatangelo; Francesco Mazzoleni
Journal:  Indian J Plast Surg       Date:  2008-01

9.  Iliotibial band friction syndrome.

Authors:  Ronald Lavine
Journal:  Curr Rev Musculoskelet Med       Date:  2010-07-20

10.  Leukotriene B4 at low dosage negates the catabolic effect of prostaglandin E2 in human patellar tendon fibroblasts.

Authors:  Bhavani P Thampatty; Hee-Jeong Im; James H-C Wang
Journal:  Gene       Date:  2006-02-20       Impact factor: 3.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.